
Founded in 2011, NRx Pharmaceuticals is a biopharmaceutical research and development company focused on bringing innovative and cost-effective treatments to difficult-to-treat diseases. We strive to overcome challenges in drug development by leveraging our research capabilities and cutting-edge technologies. Through clinical trials, we actively seek out new ways to optimize patient care and improve safety and efficacy.